Tag: SARS-CoV-2
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir
KOCHI: Glenmark Pharmaceuticals Ltd. – a global research-led pharmaceutical company – today announced top-line results.
Antibody Levels in Patients with Mild COVID-19 Decline Rapidly, Scientists Say
LOS ANGELES: In people with mild cases of COVID-19, antibodies against the novel coronavirus may.
Phase II Trial Finds Chinese COVID-19 Vaccine is Safe, Induces Immune Response
BEIJING: A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has.
COVID-19: RGCB Products for Pandemic Management Get Manufacturing License
THIRUVANANTHAPURAM: A cost-effective Rapid Antibody Card, developed indigenously by Government of India’s Rajiv Gandhi Centre.
WHO Team to Reach China Next Week to Probe SARS-CoV-2 Source
NEW DELHI: The World Health Organization is finally sending a team to China next week.
Signify and Boston University Validate Effectiveness of Signify’s UV-C Light Sources
NETHERLANDS: Signify (Euronext: LIGHT), the world leader in lighting, together with the National Emerging Infectious.
Livinguard Technologies Unmasks the Mask for a COVID-free World
GOA: With the development of medication to combat the novel coronavirus still in the works,.
High BP Drugs Safe for Patients with COVID-19 Disease: Study
NEW YORK: Despite concerns expressed by some experts, common high blood pressure drugs did not.